Data gathered: December 11
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | N/A | N/A | |
Sentiment | N/A | N/A | |
Webpage traffic | N/A | N/A | |
Employee Rating | N/A | N/A | |
Google Trends | N/A | N/A | |
Linkedin Employees | N/A | N/A | |
Patents | N/A | N/A | |
4chan Mentions | N/A | N/A | |
Facebook Engagement | N/A | N/A | |
Facebook followers | N/A | N/A | |
Stocktwits Mentions | N/A | N/A | |
Stocktwits Subscribers | N/A | N/A | |
Twitter Followers | N/A | N/A | |
Youtube Subscribers | N/A | N/A | |
News Mentions | N/A | N/A | |
Reddit Mentions | N/A | N/A | |
Business outlook | N/A | N/A |
In the news
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host DiseaseDecember 10 - Yahoo |
|
![]() |
Wall Street Breakfast: The Week AheadDecember 9 - SeekingAlpha |
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition ProgramDecember 8 - GlobeNewswire |
|
Incyte Corp. stock underperforms Friday when compared to competitorsDecember 8 - MarketWatch |
|
Catalyst Watch: Intel's AI event, Oracle earnings and CAVA IPO lockup expirationDecember 7 - Seeking Alpha |
|
Incyte Corp. stock underperforms Thursday when compared to competitorsDecember 7 - MarketWatch |
About Incyte
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally.

Price | $56.79 |
Target Price | Sign up |
Market Cap | $12.3B |
Dividend Yield | 0.0059 |
Industry | Biotechnology |
Similar companies
Company | Price | AI Score |
---|
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 918M | 60M | 858M | 171M | 261M |
Q2 '23 | 954M | 68M | 886M | 204M | 265M |
Q1 '23 | 808M | 57M | 751M | 22M | 64M |
Q4 '22 | 929M | 59M | 870M | 28M | 121M |
Q3 '22 | 823M | 55M | 768M | 113M | 145M |
Insider Transactions
SWAIN PAULA J filed to sell 77,530 shares at $65.1. September 6 '23 |
Stein Steven H filed to sell 97,583 shares at $63.3. August 3 '23 |
Pasquale Maria E filed to sell 68,524 shares at $84.1. February 2 '23 |
Pasquale Maria E filed to sell 68,524 shares at $84.7. February 1 '23 |
Dhanak Dashyant filed to sell 53,263 shares at $85. January 30 '23 |